Bullboard Post History

by prophetoffactz

Order by:

T.CSCI	RE:Avenanthramide A risk for the trial is the number of potential non-responders. Everyone may... 15 hours ago
T.CSCI	Avenanthramide Previous research on avenanthramides has shown dose-dependent absorption. In... 18 hours ago
T.CSCI	TSX Percentage Gainers TSX Percent Gainers Symbol ... 2 days ago
T.CSCI	Only three days with higher volume in the last year in US 70,000 shares. 2 days ago
T.CSCI	58,000 shares in the US Highest volume in many months. 2 days ago
T.CSCI	2025 With 4 million shares $20 is an C$80 million market cap.The previously... 2 days ago
T.CSCI	RE:Dr. Li's YouTube Channel CSCI's avenanthramide wound healing program was suppose to be ready for... 2 days ago
T.CSCI	Down 62.5% in 2024 From $10.28 to $3.86. 5 days ago
T.URB	NAV: December 27, 2024 $11.42 December 27, 2024 $11.4EOMEOm 5 days ago
T.CSCI	Q1 and PGX: In Q1 2025 CSCI could we have... 1) Health Canada approval for PGX-YBG as an... 6 days ago
T.MBX	Dr. Leana Wen calls to get testing out there and vaccinate Disclose.tv on X: "JUST IN - Dr. Leana Wen is calling on the Biden... 7 days ago
T.MBX	Dr. Deborah Birx calls for mass testing Shadow of Ezra on X: "Dr. Deborah Birx, former White House Coronavirus... 8 days ago
T.CSCI	2025: "...well-positioned for a transformational year.” "We are looking to kick off 2025 with a clear line of sight towards... 9 days ago
V.PTK	Today: Double Top Breakout Poet: Ai at the speed of light. 10 days ago
V.PTK	Poet: Ai at the speed of light... Poet: Ai at the speed of light... In the age of intelligence. 10 days ago
T.CSCI	Cosciens Biopharma - At the earliest possible time... Science is now pushing to treat inflammation and heart disease a decade... 10 days ago
T.CSCI	RE:New published study strengthens the case for CSCI's trial: Avenanthramide: "Target Identification: The study identified 109... 12 days ago
T.CSCI	New published study strengthens the case for CSCI's trial: Perplexity Ai's take: This study provides compelling evidence for the... 12 days ago
T.CSCI	New website If the new Juvente website reflects the talent of CSCI's marketing... 12 days ago
T.CSCI	PGX-YBG/Avenanthramide for osteoarthritis The favorable safety profile of avenanthramide suggests a potential advantage... 12 days ago

Become a member today, It's free!

Bullboard Post History

by prophetoffactz

RE:Avenanthramide

Avenanthramide

TSX Percentage Gainers

Only three days with higher volume in the last year in US

58,000 shares in the US

2025

RE:Dr. Li's YouTube Channel

Down 62.5% in 2024

NAV: December 27, 2024 $11.42

Q1 and PGX:

Dr. Leana Wen calls to get testing out there and vaccinate

Dr. Deborah Birx calls for mass testing

2025: "...well-positioned for a transformational year.”

Today: Double Top Breakout

Poet: Ai at the speed of light...

Cosciens Biopharma - At the earliest possible time...

RE:New published study strengthens the case for CSCI's trial:

New published study strengthens the case for CSCI's trial:

New website

PGX-YBG/Avenanthramide for osteoarthritis

Featured Company

JZR Gold Inc. V.JZR

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by prophetoffactz

Featured Company